ARCHIVES

Herceptin Reduces Recurrence In Early HER2+ Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

Clinical Oncology Program Overview Updates Ongoing Trials

December 8, 1989

FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended

July 28, 1989

Radiology Advocated As First Diagnostic Test After Hemoccult

April 25, 1986

Shubik Subcommittee Fails To Agree On Draft Document

February 13, 1976

Low-Dose Aspirin Cuts Risk Of Colorectal Growths

April 26, 2002

House Bill, Report Do Not Include Any Earmarks Or Directives To Aid CCOP, Centers, Cancer Control

August 7, 1987